Biobanking Transforming Personalized Medicine Ecosystem with Data on Biomarkers The collected terabytes of biological data and its associated information are revolutionizing healthcare infrastructure across nations. Likewise, stakeholders in the biobanking market are increasing their focus on personalized medicines to meet the growing demand for the specific diagnosis for rare-case diseases. In 2017 , North America topped the list of major countries in the world, and contributed ~ 17% of its GDP towards healthcare spending. Correspondingly, North America is projected to dominate market revenue throughout the forecast period in the biobanking market. Healthcare companies are seeking result-oriented outcomes in personalized medicine space though the development of new drugs. This is being made possible with the help of high-quality biospecimens from biobanks. Thus, stakeholders in the biobanking market and healthcare companies are closely related, as the early ...
Today, healthcare organizations operate in a dynamic ecosystem, wherein they are required to adopt unprecedented advancements for diagnostics and therapeutics, every now and then. Healthcare organizations are facing the uphill task to incorporate technological driven processes, and deliver managed care to the discerning consumer.